Policy and legislative efforts to address the threat FDA GLP-1 compounding guidance: In April, the FDA reiterated that state-licensed 503A pharmacies may only compound for individual needs without copying commercial drugs and that federally-registered 503B outsourcing facilities are limited to bulk compounding substances on the 503B bulks or drug shortage lists
Compared to controls, children with obesity presented higher concentrations in a variety of metabolites involved in energy homeostasis, branched-chain and aromatic amino acids, markers of oxidative stress, and nucleotide catabolites in both biological matrices, while other metabolic increments were exclusive for plasma (e.g., steroid hormones, bile acids) or erythrocytes (e.g., carnitine derivatives, methionine, N-acetylspermine, sphingolipids)
It works very differently from GLP-1 medications because it does not change appetite or fullness signals
The biggest problem is that there are few to no sublingual tablet NMN studies to rely on for dosing clarity
As a plastic surgeon, I discuss semaglutide with particular attention to surgical timing and anesthesia safety
Tirzepatide targets two receptors: GLP-1R and GIPR
